- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Apixaban – March 2013
Apixaban, tablet, 2-5 mg and 5 mg, Eliquis®
Last updated
8 November 2023